It's time for academics to take back control of research journals: The evolution to a high-profit industry was never planned.
It's time for academics to take back control of research journals: The evolution to a high-profit industry was never planned. Academics need to make the case for lower-cost journals
Source: theguardian.com
Biosimilar drugs could save up to $110 billion by 2020 - IMS : Lower-cost copies of complex biotech drugs, known as biosimilars,
Biosimilar drugs could save up to $110 billion by 2020 - IMS : Lower-cost copies of complex biotech drugs, known as biosimilars, could save the United States and Europe's five top markets as much as 98 billion euros ($110 bln) by 2020, a new analysis showed on Tuesday.
Source: reuters.com
RSS feed